<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03190031</url>
  </required_header>
  <id_info>
    <org_study_id>2016-A01652-49</org_study_id>
    <nct_id>NCT03190031</nct_id>
  </id_info>
  <brief_title>Respiratory Muscle Training in CF Patients</brief_title>
  <acronym>MUCOMUREE</acronym>
  <official_title>Respiratory Muscle Training in Patients With Cystic Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study aims at evaluating the effect of respiratory muscle training in adult
      patients with cystic fibrosis on lung function, exercise performance and quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">January 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The patients will be randomized in 2 different groups, one being involved in an endurance respiratory muscle training program, the other being involved in resistance inspiratory muscle training.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory muscle endurance</measure>
    <time_frame>Change from baseline (i.e. T0) measured immediately after the 8 weeks of intervention (T1)</time_frame>
    <description>Total breathing duration (in min) measured during an incremental hyperpnea test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory muscle strength</measure>
    <time_frame>Change from baseline (i.e. T0) measured immediately after the 8 weeks of intervention (T1)</time_frame>
    <description>Peak pressure (in mmHg) during maximal inspiratory and expiratory maneuvers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal cycling performance</measure>
    <time_frame>Change from baseline (i.e. T0) measured immediately after the 8 weeks of intervention (T1)</time_frame>
    <description>Peak maximal power output (in W) during an incremental cycling test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Change from baseline (i.e. T0) measured immediately after the 8 weeks of intervention (T1)</time_frame>
    <description>Score obtained during the questionnaire CQF14+</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Respiratory Muscles</condition>
  <arm_group>
    <arm_group_label>Endurance respiratory muscle training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention consists in performing isocapnic hyperpnea at 70-80% of maximal voluntary ventilation for 20 min, 5 times a week, for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistance inspiratory muscle training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The intervention consists in performing inspiratory resistive breathing at 70-80% of maximal inspiratory pressure for 20 min, 5 times a week, for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endurance respiratory muscle training</intervention_name>
    <description>Training program of the respiratory muscles in endurance by using sustained isocapnic hyperpnea</description>
    <arm_group_label>Endurance respiratory muscle training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance inspiratory muscle training</intervention_name>
    <description>Training program of the inspiratory muscles in resistance by using repeated inspiratory maneuvers against a resistance</description>
    <arm_group_label>Resistance inspiratory muscle training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a clinical diagnosis of cystic fibrosis

          -  Patients in steady state

        Exclusion Criteria:

          -  Patients during exacerbation

          -  Patients treated by oral corticotherapy (&gt;0.5 mg/kg/j during &gt;7 days) during the past
             2 months

          -  Pregnant patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Samuel Verges, PhD</last_name>
    <phone>476766860</phone>
    <phone_ext>+33</phone_ext>
    <email>sverges@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aida Mandzo</last_name>
    <phone>4 76 76 68 16</phone>
    <phone_ext>+33</phone_ext>
    <email>amandzo@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aida Mandzo</last_name>
      <phone>4 76 76 68 16</phone>
      <phone_ext>+33</phone_ext>
      <email>imandzo@chu-grenoble.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2017</study_first_submitted>
  <study_first_submitted_qc>June 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2017</study_first_posted>
  <last_update_submitted>June 15, 2017</last_update_submitted>
  <last_update_submitted_qc>June 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>training</keyword>
  <keyword>exercise</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

